IP Library Granted Patent US 12,453,702
Granted Patent B2
US 12,453,702 · App. 18/500,199 · Granted Oct 28, 2025

Apparatus and method for cryogranulating a pharmaceutical composition

Inventors: Edwin Amoro (West Haven, CT); Karel Vanackere (Knokke-Heist, BE); Michael A. White (Brookfield, CT)
Assignee: MannKind Corporation
A61K9/1682A61J3/00A61K9/16A61K9/1617A61K38/28B01J2/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,453,702
App. No.
18/500,199
Granted
Oct 28, 2025
Kind
B2
Abstract

Cryogranulation systems with improved dispenser assemblies are provided for use in manufacturing frozen pellets of pharmaceutical substances in a fluid medium. Methods of cryogranulating the pharmaceutical substance in the fluid medium are also provided. In particular embodiments, the dispenser assembly is used with suspensions or slurries of pharmaceutical compositions including biodegradable substances, such as proteins, peptides, and nucleic acids. In certain embodiments, the pharmaceutical substance can be adsorbed to any pharmaceutically acceptable carrier particles suitable for making pharmaceutical powders. In one embodiment, the pharmaceutical carrier can be, for example, diketopiperazine-based microparticles. The dispenser assembly improves the physical characteristics of the cryopellets formed and minimizes product loss during processing.

Claims (14)

1 . A dispenser assembly for supplying a fluid into a cooling agent in a cryogranulation system, comprising:

a housing and a dispenser subassembly, the housing configured to mount the dispenser subassembly above the cooling agent, the dispenser subassembly including an enclosure defining an interior chamber, at least one inlet port coupled to the interior chamber and a plurality of dispenser ports, wherein the dispenser ports of the dispenser subassembly include first and second rows of dispenser ports, the first and second rows of dispenser ports being angled with respect to vertical, and wherein the dispenser ports of the first row are disposed at opposite angles with respect to the dispenser ports of the second row.

2 . The dispenser assembly as defined in claim 1 , wherein the dispenser ports each include an upper conduit of a first inner diameter and a lower conduit of a second inner diameter.

3 . The dispenser assembly as defined in claim 2 , wherein the first inner diameter is smaller than the second inner diameter.

4 . The dispenser assembly as defined in claim 2 , wherein each upper conduit has a diameter of about one millimeter and each lower conduit has a diameter of about three millimeters.

5 . The dispenser assembly as defined in claim 2 , wherein at least the lower conduits of the dispenser ports are angled with respect to vertical.

6 . The dispenser assembly as defined in claim 1 , wherein the dispenser ports of the first row are offset in a direction of the first and second rows with respect to the dispenser ports of the second row.

7 . The dispenser assembly as defined in claim 1 , wherein the housing is configured to mount the dispenser subassembly with the first and second rows of dispenser ports disposed perpendicularly with respect to a flow of the cooling agent.

8 . The dispenser assembly as defined in claim 1 , wherein the dispenser ports are configured to dispense a pharmaceutical composition including diketopiperazine-based microparticles in a fluid medium.

9 . A method for supplying a fluid into a cooling agent in a cryogranulation system, comprising:

providing a dispenser assembly including an enclosure defining an interior chamber and a plurality of dispenser ports;

supplying the fluid to the interior chamber of the dispenser assembly; and

dispensing the fluid from the interior chamber through the dispenser ports into the cooling agent, wherein the dispenser ports of the dispenser assembly include first and second rows of dispenser ports, the first and second rows of dispenser ports being angled with respect to vertical, and wherein the dispenser ports of the first row are disposed at opposite angles with respect to the dispenser ports of the second row.

10 . The method as defined in claim 9 , wherein dispensing the fluid comprises dispensing a pharmaceutical composition including diketopiperazine-based microparticles in a fluid medium.

Assignments (2)
PATENT SECURITY AGREEMENT Recorded Aug 12, 2025
From: MANNKIND CORPORATION
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 072445/0769 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2023
From: AMORO, EDWIN; VANACKERE, KAREL; WHITE, MICHAEL A.
To: MANNKIND CORPORATION
Reel/Frame 065581/0846 →
Continuity (8)
Continuation 17363162 · Jun 30, 2021
Continuation 16675471 · Nov 6, 2019
Division 16051645 · Aug 1, 2018
Continuation 15407375 · Jan 17, 2017
Division 14065609 · Oct 29, 2013
Continuation 12917623 · Nov 2, 2010
Provisional Application 61257385 · Nov 2, 2009
Related Publication 20240074976A1 · Mar 7, 2024
References Cited (68)
US 3228838A · Rinfret et al. · 1966 [cited by applicant]
US 3298188A · Webster et al. · 1967 [cited by applicant]
US 4479363A · Gibson et al. · 1984 [cited by applicant]
US 4655047A · Temple et al. · 1987 [cited by applicant]
US 4843840A · Gibson · 1989 [cited by applicant]
US 4982577A · Milankov et al. · 1991 [cited by applicant]
US 5096746A · Strizki · 1992 [cited by applicant]
US 5352461A · Feldstein et al. · 1994 [cited by applicant]
US 5401502A · Wunderlich et al. · 1995 [cited by applicant]
US 5405616A · Wunderlich et al. · 1995 [cited by applicant]
US 5503852A · Steiner et al. · 1996 [cited by applicant]
US 5522227A · Appolonia · 1996 [cited by applicant]
US 6071497A · Steiner et al. · 2000 [cited by applicant]
US 6216470B1 · Kosock et al. · 2001 [cited by applicant]
US 6331318B1 · Milstein · 2001 [cited by applicant]
US 6444226B1 · Steiner et al. · 2002 [cited by applicant]
US 6652885B2 · Steiner et al. · 2003 [cited by applicant]
US 6770300B1 · Hoffman et al. · 2004 [cited by applicant]
US 6815533B1 · Baker et al. · 2004 [cited by applicant]
US 7062924B2 · Irvine et al. · 2006 [cited by applicant]
US 7475554B2 · Irvine et al. · 2009 [cited by applicant]
US 7648960B2 · Steiner et al. · 2010 [cited by applicant]
US 7943572B2 · Cheatham et al. · 2011 [cited by applicant]
US 8590320B2 · Amoro et al. · 2013 [cited by applicant]
US 9566243B2 · Amoro et al. · 2017 [cited by applicant]
US 10052285B2 · Amoro et al. · 2018 [cited by applicant]
US 10500159B2 · Amoro et al. · 2019 [cited by applicant]
US 11077063B2 · Amoro et al. · 2021 [cited by applicant]
US 11839688B2 · Amoro et al. · 2023 [cited by applicant]
US 20040018152A1 · Steiner et al. · 2004 [cited by applicant]
US 20050232930A1 · Richter-Friss et al. · 2005 [cited by applicant]
US 20070051117A1 · Irvine et al. · 2007 [cited by applicant]
US 20070196503A1 · Wilson et al. · 2007 [cited by applicant]
US 20080060213A1 · Gehrmann et al. · 2008 [cited by applicant]
US 20080260838A1 · Hokenson et al. · 2008 [cited by applicant]
US 20090110647A1 · Richardson et al. · 2009 [cited by applicant]
US 20090111749A1 · Richardson et al. · 2009 [cited by applicant]
US 20110100028A1 · Amoro et al. · 2011 [cited by applicant]
US 20140044790A1 · Amoro et al. · 2014 [cited by applicant]
US 20170119673A1 · Amoro et al. · 2017 [cited by applicant]
US 20180338920A1 · Amoro et al. · 2018 [cited by applicant]
US 20200069590A1 · Amoro et al. · 2020 [cited by applicant]
US 20210322320A1 · Amoro et al. · 2021 [cited by applicant]
JP 11236336A2 · 1999 [cited by applicant]
JP 2009507931T2 · 2009 [cited by applicant]
RU 2248790C2 · 2005 [cited by applicant]
SU 1669730A1 · 1991 [cited by applicant]
WO WO0006179A1 · 2000 [cited by applicant]
WO WO03020959A1 · 2003 [cited by applicant]
WO WO03028486A2 · 2003 [cited by applicant]
WO WO2005058474A1 · 2005 [cited by applicant]
WO WO2007057888A2 · 2007 [cited by applicant]
WO WO2007098500A2 · 2007 [cited by applicant]
WO WO2009055742A1 · 2009 [cited by applicant]
WO WO2010003430A1 · 2010 [cited by applicant]
WO WO2011053959A1 · 2011 [cited by applicant]
International Search Report and Written Opinion dated Jan. 10, 2011, in connection with International Application No. PCT/US2010/55085. [cited by applicant]
Extended European Search Report dated Feb. 28, 2013, in connection with European Application No. 10827637.9. [cited by applicant]
Extended European Search Report dated Jul. 2, 2019, in connection with European Application No. 18215323.9. [cited by applicant]
Australian Examination Report dated Apr. 21, 2016, in connection with Australian Application No. AU 2015201885. [cited by applicant]
Chinese Office Action dated Sep. 19, 2016, from Chinese Application No. 201410219078.2. [cited by applicant]
Japanese Office Action mailed Feb. 4, 2016, in connection with Japanese Application No. 2012-537187. [cited by applicant]
Japanese Office Action dated Aug. 24, 2016, in connection with Japanese Application No. 2015-202462. [cited by applicant]
Russian Office Action dated Jul. 23, 2021, in connection with Russian Application No. 2017141631. [cited by applicant]
Russian Office Action mailed Feb. 10, 2022, in connection with Russian Application No. 2017141631. [cited by applicant]
Jeedigunta et al., Diketopiperazines as Advanced Intermediates in the Biosynthesis of Ecteinascidins. Tetrahedon. 2000;56:3303-7. [cited by applicant]
Hall et al., Capturing Lightning in a Bottle. http://www.pharmpro.com/Articles/2010/07/Capturing-Lightning-In-A-Bottle/, Jul. 16, 2010, 7 pages. [cited by applicant]
Kolosov et al., Freezing of Granules in an Apparatus for Cryogranulation of Liquid Materials. Journal of Engineering Physics, Apr. 1991, vol. 60, Issue 4, pp. 463-467. [cited by applicant]